DELIVRA HEALTH BRANDS INC (DHB.CA) Stock Price, Forecast & Analysis
Canada - TSX-V:DHB - CA24703H2019 - Common Stock
DHB.CA Key Statistics, Chart & Performance
The current stock price of DHB.CA is 0.29 CAD. In the past month the price decreased by -6.45%. In the past year, price increased by 45%.
DHB.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.59 | 3.14B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.53B | ||
| CRON.CA | CRONOS GROUP INC | 23.79 | 1.28B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.47 | 894.63M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 5.26 | 623.65M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 122.6 | 611.04M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 500.61M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 21.09 | 341.82M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 341.44M | ||
| HITI.CA | HIGH TIDE INC | N/A | 331.47M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 284.78M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 267.95M |
Related stock screener links
About DHB.CA
Company Profile
Delivra Health Brands, Inc. is a cannabis company, which engages in the development and provision of health and wellness packaged goods to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. The company features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.
Company Info
DELIVRA HEALTH BRANDS INC
Suite 404, 999 Canada Place
Vancouver BRITISH COLUMBIA CA
Employees: 27
Phone: 16044499280
DELIVRA HEALTH BRANDS INC / DHB.CA FAQ
Can you describe the business of DELIVRA HEALTH BRANDS INC?
Delivra Health Brands, Inc. is a cannabis company, which engages in the development and provision of health and wellness packaged goods to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. The company features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.
What is the stock price of DELIVRA HEALTH BRANDS INC today?
The current stock price of DHB.CA is 0.29 CAD.
Does DHB stock pay dividends?
DHB.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of DHB stock?
DHB.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is DELIVRA HEALTH BRANDS INC (DHB.CA) expected to grow?
The Revenue of DELIVRA HEALTH BRANDS INC (DHB.CA) is expected to grow by 13.99% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
DHB.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to DHB.CA. When comparing the yearly performance of all stocks, DHB.CA is one of the better performing stocks in the market, outperforming 83.02% of all stocks.
DHB.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DHB.CA. DHB.CA may be in some trouble as it scores bad on both profitability and health.
DHB.CA Financial Highlights
Over the last trailing twelve months DHB.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -274.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.42% | ||
| ROE | -28.14% | ||
| Debt/Equity | 0.43 |
DHB.CA Forecast & Estimates
9 analysts have analysed DHB.CA and the average price target is 0.73 CAD. This implies a price increase of 153.24% is expected in the next year compared to the current price of 0.29.
For the next year, analysts expect an EPS growth of 80% and a revenue growth 13.99% for DHB.CA